Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
114.05
+5.05 (4.63%)
Apr 24, 2025, 3:14 PM EDT - Market open
CRL Employees
Charles River Laboratories International had 20,100 employees as of December 31, 2024. The number of employees decreased by 1,700 or -7.80% compared to the previous year.
Employees
20,100
Change (1Y)
-1,700
Growth (1Y)
-7.80%
Revenue / Employee
$201,492
Profits / Employee
$512
Market Cap
5.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20,100 | -1,700 | -7.80% |
Dec 31, 2023 | 21,800 | 400 | 1.87% |
Dec 31, 2022 | 21,400 | 1,400 | 7.00% |
Dec 25, 2021 | 20,000 | 1,600 | 8.70% |
Dec 26, 2020 | 18,400 | 1,300 | 7.60% |
Dec 28, 2019 | 17,100 | 2,400 | 16.33% |
Dec 29, 2018 | 14,700 | 2,900 | 24.58% |
Dec 30, 2017 | 11,800 | 800 | 7.27% |
Dec 31, 2016 | 11,000 | 2,400 | 27.91% |
Dec 26, 2015 | 8,600 | 700 | 8.86% |
Dec 27, 2014 | 7,900 | 200 | 2.60% |
Dec 28, 2013 | 7,700 | 500 | 6.94% |
Dec 29, 2012 | 7,200 | 100 | 1.41% |
Dec 31, 2011 | 7,100 | -400 | -5.33% |
Dec 25, 2010 | 7,500 | -500 | -6.25% |
Dec 26, 2009 | 8,000 | -1,000 | -11.11% |
Dec 27, 2008 | 9,000 | 500 | 5.88% |
Dec 29, 2007 | 8,500 | 500 | 6.25% |
Dec 30, 2006 | 8,000 | -400 | -4.76% |
Dec 31, 2005 | 8,400 | 400 | 5.00% |
Dec 25, 2004 | 8,000 | 3,500 | 77.78% |
Dec 27, 2003 | 4,500 | -500 | -10.00% |
Dec 28, 2002 | 5,000 | 1,000 | 25.00% |
Dec 29, 2001 | 4,000 | 500 | 14.29% |
Dec 30, 2000 | 3,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CRL News
- 2 days ago - Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development - Business Wire
- 8 days ago - Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call - Business Wire
- 13 days ago - What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday? - Benzinga
- 4 weeks ago - Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform - Business Wire
- 6 weeks ago - Charles River Laboratories to Present at Barclays Global Healthcare Conference - Business Wire
- 7 weeks ago - FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility - Business Wire
- 2 months ago - Charles River Announces Agreement with Singapore General Hospital - Business Wire
- 2 months ago - Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance - Benzinga